Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma
Clinical trial NCT01467986 · COMPLETED
Trial details
- NCT number
- NCT01467986
- Sponsor
- University of Regensburg
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2020-09-30
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.